Shire Pharmaceuticals Group Plc
Shire Adds new Technology Platform and Phase 2 Product Candidate to its Regenerative Medicine Business
Dublin (ots/PRNewswire) - Shire plc , the global specialty biopharmaceutical company, today announced that it has signed an agreement to acquire substantially all the assets of Pervasis Therapeutics. Shire will provide Pervasis with an upfront payment, plus potential post-closing milestone payments that are dependent on Shire's achievement of certain clinical ...
plus